The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...
Hosted on MSN1mon
HeartBeam submits 510(k) application to FDA for ECG softwareEnrolment for the study concluded in June 2024. Findings from the study suggest that synthesised 12-lead ECG is clinically equivalent to standard ECGs for rhythm and arrhythmia assessment.
It was tested in a prospective, single-blind study of 200 heart patients against the standard traditional 12-lead EKG ...
Greetings and welcome to the HeartBeam fourth-quarter and full year 2024 financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded. Before we ...
The Company continues to make steady progress toward commercial readiness, and key clinical and regulatory milestones on the ...
One can either use calculated sums of the amplitudes of QRS complexes of all 12 leads ... that the use of the ECG along these lines in the care of patients with CHF will lead to further progress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback